Tech Company Financing Transactions
SPR Therapeutics Funding Round
Frontcourt Ventures and private investors participated in a $25 million Series C funding round for SPR Therapeutics. This VC investment round was recorded on 9/13/2017.
Transaction Overview
Company Name
Announced On
9/13/2017
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series C
Investors
Frontcourt Ventures (Lead Investor)
Proceeds Purpose
The investment will be used to commercialize its FDA-cleared SPRINT Peripheral Nerve Stimulation (PNS) System and to fund additional research across multiple indications including post-surgical acute pain and chronic low back pain.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
22901 Millcreek Blvd. 110
Cleveland, OH 44122
USA
Cleveland, OH 44122
USA
Phone
Website
Email Address
Overview
SPR Therapeutics is a medical device company that is commercializing pain treatments utilizing its proprietary peripheral nerve stimulation (PNS) products. We are developing a pipeline of neurostimulation pain therapies that will exploit the same physiologic mechanism of action, proprietary technology, and clinical approach.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Maria Bennett
Chief Medical Officer
John Chae
Chief Scientific Officer
Warren Grill
VP - Marketing
Mark Stultz
VP - R & D
Joseph Boggs
VP - Sales
David Youngberg
Browse more venture capital transactions:
Prev: 9/13/2017: Aria Systems venture capital transaction
Next: 9/13/2017: 23andMe venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs